Pancreatic Cancer Research

ResearcherUniversity of FlorenceActive in the last 2 years

Angelica Sette

Matched on ORCID iD 0000-0002-3757-5583; OpenAlex author ID A5015493591. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 3

  1. Retraction Note: Development of novel anti-Kv 11.1 antibody-conjugated PEG-TiO2 nanoparticles for targeting pancreatic ductal adenocarcinoma cells. Co-author DOI 10.1007/s11051-025-06264-8↗
  2. hERG1 channels drive tumour malignancy and may serve as prognostic factor in pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/bjc.2015.28↗
  3. Development of novel anti-Kv 11.1 antibody-conjugated PEG-TiO2 nanoparticles for targeting pancreatic ductal adenocarcinoma cells. Co-author DOI 10.1007/s11051-013-2111-6↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Annarosa Arcangeli · 3 shared papers, 2013–2025 · strength 0.36
  2. Jolanda Spadavecchia · 2 shared papers, 2013–2025 · strength 0.32
  3. Sagar S. Manoli · 1 shared paper, 2015 · strength 0.04
  4. Lapo Bencini · 1 shared paper, 2015 · strength 0.04
  5. Domenico Borzomati · 1 shared paper, 2015 · strength 0.04
  6. Elena Lastraioli · 1 shared paper, 2015 · strength 0.04
  7. Gennaro Nappo · 1 shared paper, 2015 · strength 0.04
  8. Francesco Di Costanzo · 1 shared paper, 2015 · strength 0.04
  9. Daniele Santini · 1 shared paper, 2015 · strength 0.04
  10. Roberto Coppola · 1 shared paper, 2015 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.